Rituximab for rheumatoid arthritis

A. López-Olivo, María; Amezaga Urruela, Matxalen; McGahan, Lynda; N. Pollono, Eduardo; E. Suarez‐Almazor, María

doi:10.1002/14651858.cd007356.pub2

Public

Rituximab for rheumatoid arthritis

Published in Cochrane Database of Systematic Reviews • Jan 20, 2015

Authors:

María A. López-Olivo

Matxalen Amezaga Urruela

Lynda McGahan

Abstract

BACKGROUND: Rituximab is a selective, B-cell depleting, biologic agent for treating refractory rheumatoid arthritis (RA). It is a chimeric monoclonal antibody targeted against CD 20 that is promoted as therapy for patients who fail to respond to other biologics. There is evidence to suggest that rit...

Subject

Rituximab

Medicine

Rheumatoid arthritis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!